Showing 2701-2710 of 4703 results for "".
Fighting for Change
https://practicaldermatology.com/topics/practice-management/fighting-for-change/23775/Unpacking the new AMA Recovery Plan for America’s physicians.Back to the Future
https://practicaldermatology.com/topics/practice-management/back-to-the-future/23073/Dermatology and dermatologists will look a lot different in 20 years. Here’s a sneak peek.Being a Leader is Good For Our Profession
https://practicaldermatology.com/topics/practice-management/being-a-leader-is-good-for-our-profession/20468/Taking on leadership roles can do much more than make you a better communicator and more effective provider.Finding Meaning in a Complicated EHR Picture
https://practicaldermatology.com/topics/practice-management/finding-meaning-in-a-complicated-ehr-picture/21302/Introducing the next edition of the EHR User series, featuring perspective on individual systems and the broader HIT picture.New Drugs in Psoriasis
https://practicaldermatology.com/topics/psoriasis/new-drugs-in-psoriasis/20933/The last two years have seen a number of new drugs approved to treat psoriasis—from targeted biologics to new topicals.Get Ready: The Biosimilars Are Here
https://practicaldermatology.com/topics/psoriasis/get-ready-the-biosimilars-are-here/20662/Recent developments mean that biosimilars are finally hitting the US market.The “Aged Microenvironment”: New Understandings of Melanoma Spread and Aggression
https://practicaldermatology.com/topics/skin-cancer-photoprotection/the-aged-microenvironment-new-understandings-of-melanoma-spread-and-aggression/20863/New research sheds light on pathways through which melanoma may become more aggressive.Recent Developments
https://practicaldermatology.com/topics/practice-management/recent-developments-49/24006/Currents
https://practicaldermatology.com/topics/practice-management/currents/21161/A Closer Look at Cibinqo for AD Management
https://practicaldermatology.com/topics/atopic-dermatitis/a-closer-look-at-cibinqo-for-ad-management/23664/Oral JAK inhibitors offer rapid onset of efficacy and some flexibility in the management of moderate to severe eczema.